Hospice Care Improvement Act of 2019

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models;HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Coronavirus Aid, Relief, and Economic Security Act (S.3548); COVID-19 emergency funding and COVID-19 related legislation; Appropriations issues for veterans in hospice

Client expense: $290,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models;HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Coronavirus Aid, Relief, and Economic Security Act (S.3548); COVID-19 emergency funding and COVID-19 related legislation; Appropriations issues for veterans in hospice

Client expense: $290,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

S. 2807, Hospice Care Improvement Act of 2019; H.R. 5821, HOSPICE Act; Homehealth and telehealth related to COVID emergency supplemental; Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act; Continued monitoring of implementation of Public Law 116-136, CARES Act; H.R. 6800, The Heroes Act; Congressional delay of Medicare Advantage carve-in proposed by CMS/CMMI; H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260); Extension of the Medicare Sequester

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues concerning the Medicare Hospice Benefit and children's hospice issues. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing, vaccines, and COVID-19 related legislation. Issues concerning hospice sequestration relief. Issues related to telehealth flexibilities and regulatory flexibilities granted under the public health emergency. Issues involving hospice providers and tax treatment and reporting requirements of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues concerning Medicare Advantage Value-Based Insurance Design. Issues pertaining to the hospice election statement and election statement addendum. Consolidated Appropriations Act, 2021 (H.R.133); ChiPACC Act of 2020 (H.R.9002); Medicare Sequester COVID Moratorium Act (H.R.8840); Compassionate Care Act (S.4945); HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); COVID-19 Hospice Respite Care Relief Act of 2020 (S.4423/H.R.8322); CONNECT Act (S. 2741/H.R. 4932); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S. 1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Eliminating the Provider Relief Fund Tax Penalties Act of 2020 (H.R.7819); National Hospice and Palliative Care Month Proclamation Request and Senate Resolution

Client expense: $240,000 · Firm income: Not reported

Issues concerning the Medicare Hospice Benefit and children's hospice issues. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing, vaccines, and COVID-19 related legislation. Issues concerning hospice sequestration relief. Issues related to telehealth flexibilities and regulatory flexibilities granted under the public health emergency. Issues involving hospice providers and tax treatment and reporting requirements of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues concerning Medicare Advantage Value-Based Insurance Design. Issues pertaining to the hospice election statement and election statement addendum. Consolidated Appropriations Act, 2021 (H.R.133); ChiPACC Act of 2020 (H.R.9002); Medicare Sequester COVID Moratorium Act (H.R.8840); Compassionate Care Act (S.4945); HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); COVID-19 Hospice Respite Care Relief Act of 2020 (S.4423/H.R.8322); CONNECT Act (S. 2741/H.R. 4932); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S. 1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Eliminating the Provider Relief Fund Tax Penalties Act of 2020 (H.R.7819); National Hospice and Palliative Care Month Proclamation Request and Senate Resolution

Client expense: $240,000 · Firm income: Not reported

S. 433/H.R. 2573, Home Health Payment Innovation Act. S. 296/H.R. 2150, Home Health Care Planning Improvement Act. Oppose home health and hospice payment cuts and co-pays. Recognition and payment for telehealth services under Medicare and Medicaid. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. S. 2080/H.R. 647, Palliative Care and Hospice Education and Training Act. S. 1190/H.R. 2594, Rural Access to Hospice Act. S. 995, Lifespan Respite Reauthorization Act. Medicare outreach and enrollment efforts to low-income beneficiaries. H.R. 2878/S. 3261 , Homecare for Seniors Act. Hospice quality of care and survey reforms. Medicaid payment and eligibility policy. Medicaid Money Follows the Person. Medicaid protections against spousal impoverishments. Medicare Home Infusion Therapy Benefit. S. 2741/ H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. S. 2807, Hospice Care Improvement Act of 2019. H.R. 5821, HOSPICE Act. Administration for Community Living falls prevention program. H.R. 6201, Families First Coronavirus Response Act. Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. No. 116-136. Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, Pub. L. No. 116-123. Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, homebound status, Medicare Sequestration, and Physician Assistants conducting hospice face-to-face. Medicare Home Health Payment Policy. H.R. 133, Consolidated Appropriations Act, 2021, provisions impacting home care and hospice. H.R. 8677/S. 4854, Home Health Emergency Access to Telehealth Act. S. 4945, Compassionate Care Act.

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; Hospice Care Improvement Act (S. 2807); the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act, H.R. 5821); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800); Issues concerning Medicare Advantage and the hospice benefit; COVID-19 Hospice Respite Care Relief Act of 2020 (H.R.8322/S. 4423); the CONNECT for Health Act of 2019(H.R.4932/S. 2741).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; Hospice Care Improvement Act (S. 2807); the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act, H.R. 5821); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800); Issues concerning Medicare Advantage and the hospice benefit; COVID-19 Hospice Respite Care Relief Act of 2020 (H.R.8322/S. 4423); the CONNECT for Health Act of 2019(H.R.4932/S. 2741).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Issues concerning Medicare Advantage and the hospice benefit. S. 4423 / H.R. 8322, COVID-19 Hospice Respite Care Relief Act of 2020 and issues involving inpatient respite care. Issues involving hospice providers and The Cares Act provider relief fund. Issues related to the corona virus. S. 2741 / H.R. 4931, CONNECT for Health Act of 2019, as it relates to use of telehealth in the recertification of a beneficiary for the hospice benefit. Monitored H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R. 133, The Continuing Appropriations Act of 2021, including issues regarding rural access to hospice services, program integrity, Medicare sequestration relief and the hospice aggregate cap.

Client expense: Not reported · Firm income: $40,000

S. 2807, Hospice Care Improvement Act of 2019; H.R. 5821, HOSPICE Act; Homehealth and telehealth related to COVID emergency supplemental; Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act; Continued monitoring of implementation of Public Law 116-136, CARES Act; H.R. 6800, The Heroes Act; Congressional delay of Medicare Advantage carve-in proposed by CMS/CMMI

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; Hospice Care Improvement Act (S. 2807); the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act, H.R. 5821); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800); Issues concerning Medicare Advantage and the hospice benefit; COVID-19 Hospice Respite Care Relief Act of 2020 (H.R.8322/S. 4423); the CONNECT for Health Act of 2019(H.R.4932/S. 2741).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; Hospice Care Improvement Act (S. 2807); the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act, H.R. 5821); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800); Issues concerning Medicare Advantage and the hospice benefit; COVID-19 Hospice Respite Care Relief Act of 2020 (H.R.8322/S. 4423); the CONNECT for Health Act of 2019(H.R.4932/S. 2741).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 433/H.R. 2573, Home Health Payment Innovation Act. S. 296/H.R. 2150, Home Health Care Planning Improvement Act. Oppose home health and hospice payment cuts and co-pays. Recognition and payment for telehealth services under Medicare and Medicaid. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. S. 2080/H.R. 647, Palliative Care and Hospice Education and Training Act. S. 1190/H.R. 2594, Rural Access to Hospice Act. S. 995, Lifespan Respite Reauthorization Act. Medicare outreach and enrollment efforts to low-income beneficiaries. H.R. 2878/S. 3261 , Homecare for Seniors Act. Hospice quality of care and survey reforms. Medicaid payment and eligibility policy. Medicaid Money Follows the Person. Medicaid protections against spousal impoverishments. Medicare Home Infusion Therapy Benefit. S. 2741/ H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. S. 2807, Hospice Care Improvement Act of 2019. H.R. 5821, HOSPICE Act. Administration for Community Living falls prevention program. H.R. 6201, Families First Coronavirus Response Act. Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. No. 116-136. Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, Pub. L. No. 116-123. Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, homebound status, Medicare Sequestration, and Physician Assistants conducting hospice face-to-face. Medicare Home Health Payment Policy.

Client expense: $130,000 · Firm income: Not reported

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Issues concerning Medicare Advantage and the hospice benefit. Issues involving palliative care and issues involving inpatient respite care. Issues involving hospice providers and The Cares Act provider relief fund. Issues related to the corona virus.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues concerning the Medicare Hospice Benefit and children's hospice issues. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing and COVID-19 related legislation. Issues related to telehealth flexibilities and regulatory flexibilities granted under the public health emergency. Issues involving hospice providers and tax treatment and reporting requirements of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues concerning Medicare Advantage Value-Based Insurance Design. Issues pertaining to the hospice election statement and election statement addendum. HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S. 2807); Rural Access to Hospice Act (H.R.2594/S.1190); COVID-19 Hospice Respite Care Relief Act of 2020 (S. 4423/H.R. 8322); CONNECT Act (S. 2741/H.R. 4932); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S. 1921); CARES Act (H.R. 748); HEROES Act (H.R. 6200); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Eliminating the Provider Relief Fund Tax Penalties Act of 2020 (H.R.7819); National Hospice and Palliative Care Month Proclamation Request and Senate Resolution

Client expense: $178,000 · Firm income: Not reported

Issues concerning the Medicare Hospice Benefit and children's hospice issues. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, extension of the public health emergency, testing and COVID-19 related legislation. Issues related to telehealth flexibilities and regulatory flexibilities granted under the public health emergency. Issues involving hospice providers and tax treatment and reporting requirements of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues concerning Medicare Advantage Value-Based Insurance Design. Issues pertaining to the hospice election statement and election statement addendum. HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S. 2807); Rural Access to Hospice Act (H.R.2594/S.1190); COVID-19 Hospice Respite Care Relief Act of 2020 (S. 4423/H.R. 8322); CONNECT Act (S. 2741/H.R. 4932); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S. 1921); CARES Act (H.R. 748); HEROES Act (H.R. 6200); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Eliminating the Provider Relief Fund Tax Penalties Act of 2020 (H.R.7819); National Hospice and Palliative Care Month Proclamation Request and Senate Resolution

Client expense: $178,000 · Firm income: Not reported

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Issues concerning Medicare Advantage and the hospice benefit. S. 4423 / H.R. 8322, COVID-19 Hospice Respite Care Relief Act of 2020 and issues involving inpatient respite care. Issues involving hospice providers and The Cares Act provider relief fund. Issues related to the corona virus. S. 2741 / H.R. 4931, CONNECT for Health Act of 2019 as it relates to use of telehealth in the recertification of a beneficiary for the hospice benefit. Monitored H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.

Client expense: Not reported · Firm income: $40,000

S. 2807, Hospice Care Improvement Act of 2019; H.R. 5821, HOSPICE Act; Homehealth and telehealth related to COVID emergency supplemental; Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act; Continued monitoring of implementation of Public Law 116-136, CARES Act; H.R. 6800, HEROES Act; Congressional delay of Medicare Advantage carve-in proposed by CMS/CMMI

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/ S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; S. 2807, the Hospice Care Improvement Act; H.R. 5821, the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647/ S. 2080); Rural Access to Hospice Act (S. 1190/H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; S. 2807, the Hospice Care Improvement Act; H.R. 5821, the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act); Issues impacting the hospice provider community related to COVID-19; Implementation of CARES Act (Public Law No: 116-136); the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act/H.R. 6800).

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Issues concerning Medicare Advantage and the hospice benefit. Issues involving palliative care and issues involving inpatient respite care. Issues involving hospice providers and The Cares Act provider relief fund. Issues related to the corona virus.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Coronavirus Aid, Relief and Economic Security Cares Act, P.L. 116-136, as it relates to COVID-19 funding for hospices.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

S. 433/H.R. 2573, Home Health Payment Innovation Act. S. 296/H.R. 2150, Home Health Care Planning Improvement Act. Oppose home health and hospice payment cuts and co-pays. Recognition and payment for telehealth services under Medicare and Medicaid. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. S. 2080/H.R. 647, Palliative Care and Hospice Education and Training Act. S. 1190/H.R. 2594, Rural Access to Hospice Act. S. 995, Lifespan Respite Reauthorization Act. Medicare outreach and enrollment efforts to low-income beneficiaries. H.R. 2878/S. 3261 , Homecare for Seniors Act. Hospice quality of care and survey reforms. Medicaid payment and eligibility policy. Medicaid Money Follows the Person. Medicaid protections against spousal impoverishments. Medicare Home Infusion Therapy Benefit. S. 2741/ H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. S. 2807, Hospice Care Improvement Act of 2019. H.R. 5821, HOSPICE Act. Administration for Community Living falls prevention program. H.R. 6201, Families First Coronavirus Response Act. Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. No. 116-136. Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, Pub. L. No. 116-123. Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, homebound status, Medicare Sequestration, and Physician Assistants conducting hospice face-to-face.

Client expense: $140,000 · Firm income: Not reported

Issues concerning the Medicare Hospice Benefit. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, COVID-19 related legislation, telehealth flexibilities, regulatory flexibilities granted under the public health emergency, and extension of the public health emergency. Issues involving hospice providers and tax treatment of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues related to palliative care for seriously ill children. Issues concerning Medicare Advantage Value Based Insurance Design. Issues related to reasonable liability protections. HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); CARES Act (H.R. 748); HEROES Act (H.R. 6200); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); National Hospice and Palliative Care Month Proclamation Request

Client expense: $170,000 · Firm income: Not reported

Issues concerning the Medicare Hospice Benefit. Issues concerning hospice payment and alternative payment models. Issues related to advanced care illness management. Issues involving inpatient respite care, bereavement funding, palliative care and a community-based palliative care demonstration. Issues related to COVID-19 emergency funding, COVID-19 related legislation, telehealth flexibilities, regulatory flexibilities granted under the public health emergency, and extension of the public health emergency. Issues involving hospice providers and tax treatment of the CARES Act Public Health and Social Services Emergency Fund. Issues concerning hospice program integrity. Issues related to palliative care for seriously ill children. Issues concerning Medicare Advantage Value Based Insurance Design. HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); CARES Act (H.R. 748); HEROES Act (H.R. 6200); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); National Hospice and Palliative Care Month Proclamation Request

Client expense: $170,000 · Firm income: Not reported

S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; S. 2807, Hospice Care Improvement Act; hospice wage index payment parity issues; COVID-19 issues involving recertification, PPE, funding under the CARES Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 433/H.R. 2573, Home Health Payment Innovation Act. S. 296/H.R. 2150, Home Health Care Planning Improvement Act. Oppose home health and hospice payment cuts and co-pays. Recognition and payment for telehealth services under Medicare and Medicaid. Home health rural add-on payment adjustment. Value based purchasing and bundling. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. S. 2080/H.R. 647, Palliative Care and Hospice Education and Training Act. S. 1190/H.R. 2594, Rural Access to Hospice Act. S. 995, Lifespan Respite Reauthorization Act. Medicare outreach and enrollment efforts to low-income beneficiaries. H.R. 2878/S. 3261 , Homecare for Seniors Act. Hospice quality of care and survey reforms. Medicaid payment and eligibility policy. Medicaid Money Follows the Person. Medicaid protections against spousal impoverishments. Medicare Home Infusion Therapy Benefit. S. 2741/ H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. S. 2807, Hospice Care Improvement Act of 2019. H.R. 5821, HOSPICE Act. Administration for Community Living falls prevention program. H.R. 6201, Families First Coronavirus Response Act. H.R. 748/S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act. H.R. 6074,Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, homebound status, Medicare Sequestration, and Physician Assistants conducting hospice face-to-face.

Client expense: $140,000 · Firm income: Not reported

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019, H.R. 5821, Helping Our Senior Population in Comfort Environments Act, and issues regarding hospice program integrity. Coronavirus Aid, Relief and Economic Security Cares Act, P.L. 116-136, as it relates to COVID-19 funding for hospices.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models;HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Coronavirus Aid, Relief, and Economic Security Act (S.3548); COVID-19 emergency funding and COVID-19 related legislation; Appropriations issues for veterans in hospice

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models;HOSPICE Act (H.R. 5821); Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); Strengthening Innovation in Medicare and Medicaid Act (H.R.5741); Coronavirus Aid, Relief, and Economic Security Act (S.3548); COVID-19 emergency funding and COVID-19 related legislation; Appropriations issues for veterans in hospice

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647 / S. 2080); Rural Access to Hospice Act (S. 1190 / H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; S. 2807/ , the Hospice Care Improvement Act; H.R. 5821, the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act); Issues impacting the hospice provider community related to COVID-19; H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647 / S. 2080); Rural Access to Hospice Act (S. 1190 / H.R. 2594); Provider Training in Palliative Care Act (S. 1921); Hospice program integrity; S. 2807/ , the Hospice Care Improvement Act; H.R. 5821, the Helping Our Senior Population in Comfort Environments Act (HOSPICE Act); Issues impacting the hospice provider community related to COVID-19; H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 433/H.R. 2573, Home Health Payment Innovation Act of 2019; S. 2807, Hospice Care Improvement Act of 2019; Hospice issues; H.R. 5821, HOSPICE Act; CY2020 Final Rule Home Health; Homehealth and telehealth related to COVID emergency supplemental; Home Health Value Based Purchasing (HHVBP) program; H.R. 6074 (Public Law 116-123) - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; H.R. 6201 (Public Law 116-127) - Families First Coronavirus Response Act; H.R. 748 (Public Law 116-136) - CARES Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act. H.R. 6201, Families First Coronavirus Response Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act - Discussed Medicare enrollment national open enrollment period, medical expense deduction, cost-sharing protections for commercial/private health insurance holders, telehealth access, nursing homes, virtual visitation, home and community-based services, Older Americans Act programs, Medicare home health care, and family caregiving, no-cost COVID-19 testing, equitable relief payments, retirement savings tax relief, suspensions of foreclosures and evictions, expanded unemployment benefits, paid sick and family leave, affordable broadband, and government operations, among other issues. S. 3517, Discussed Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). S. 753/H.R. 1682, Improving Access to Medicare Coverage Act. H.R. 6305, To assist older Americans and people with disabilities affected by COVID-19.; S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act. H.R. 6379, Take Responsibility for Workers and Families Act. Discussed Medicaid HCBS grants and virtual visitation provisions. No bill number, discussed Nursing Home Modernization Reform Act of 2019. No bill number, discussed Elder Justice Act Reauthorization and nursing home bill. S. 2807, discussed Hospice Care Improvement Act of 2019. H.R. 1343, Protecting Married Seniors from Impoverishment Act. Discussed Medicaid home and community-based services and family financial impacts. No bill number. Discussed nursing homes, criminal background checks, inappropriate use of anti-psychotropic drugs, guardianship, and Elder Justice Act Reauthorization. H.R. 5821, Helping Our Senior Population in Comfort Environments (HOSPICE) Act. Discussed HOSPICE Act and live discharges of long-term terminally ill individuals from hospice. S. 3277; Discussed feedback on HCBS Infrastructure Improvement Act and the bill. No bill number. Discussed long-term services and supports financing legislation, Social Security, Administrations Medicaid guidance, and Ways and Means Caring for Aging Americans hearing statement from November 2019. No bill number. Discussed family caregiving supports, Medicare Advantage (MA) Value-Based Insurance Design (VBID) Demonstration, and the MA VBID hospice demonstration component. H.R. 5821, Helping Our Senior Population in Comfort Environments Act. No bill number. Discussed issues impacting dual-eligibles. S. 296/H.R.2150, Home Health Care Planning Improvement Act. No bill number. CMS nursing home Coronavirus guidance. No bill number. Discussed nursing home virtual visitation. S. 3548/H.R. 748, P.L. 116-136, CARES Act Lobbied regarding nursing homes, virtual visitation, home and community-based services, Older Americans Act programs, Medicare home health care, and family caregiving. S.1999 - Improving Low Income Access to Prescription Drugs Act. H.R. 3, the Lower Drug Costs Now Act. S. 2543, the Prescription Drug Pricing Reduction Act. No bill number - Discussed surprise medical billing. H.R. 5800 - Ban Surprise Billing Act. H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act. No bill number - Discussed Alaska-specific nursing home legislation.

S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; S. 2807, Hospice Care Improvement Act; hospice wage index payment parity issues; COVID-19 issues involving recertification, PPE, funding under the CARES Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; S. 2807, Hospice Care Improvement Act; hospice wage index payment parity issues; COVID-19 related issues involving recertification, PPE, and funding.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act (Klobuchar) - Part D price negotiations S. 99, Medicare Drug Price Negotiation Act (Sanders) - Part D price negotiations, formulary changes S. 205, Right Rebate Act (Wyden) - Medicaid drug rebate program S. 317, ACE Kids Act (Grassley) - health homes for children with medically complex conditions S. 377, Medicare Negotiation and Competitive Licensing Act (Brown) - Part D price negotiation S. 470, Medicare at 50 Act (Stabenow) - Medicare buy-in option S. 475, RxCAP Act (Wyden) - Part D cost-sharing S. 489, State Public Option Act (Schatz) - Medicaid buy-in option S. 516, Prescription Drug Monitoring Act (Klobuchar) - required use of PDMPs S. 548, EMPOWER Care Act (Portman) - MFP demonstration S. 640, Phair Pricing Act (Kennedy) -- Part D rebates at the point of sale S. 691, Medicare Extra Rx HELP Act (Casey) - Part D assistance for low-income seniors S. 709, Prescription Drug Pricing Dashboard Act (Casey) - interactive dashboard with drug price and utilization data for federal programs S. 773, Telehealth Innovation and Improvement Act (Gardner) - testing expanded coverage of telehealth services in Medicare S. 988, Improving Transparency and Accuracy in Medicare Part D Spending Act (Capito) - payments on clean claims S. 1114, Medicare Advantage Quality Payment Relief Act (Daines-King) - MA benchmark cap S. 2081, Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019 (Peters)- drugs in Part B S. 2252, Empowering States to Address Drug Costs Act (Van Hollen)- drug pricing S. 2446, Medicare Audiologist Access and Services Act of 2019 (Warren)-Medicare coverage of audiologist services S. 2650 - Medicare Prescription Drug Savings and Choice Act of 2019 (Durbin) - lowering prescription drug costs S. 2807, Hospice Care Improvement Act of 2019 (Portman) - Medicare hospice programs S. 2846, Protecting Patients Transportation to Care Act (Isakson) - Medicaid coverage of transportation S. 2911, Seniors Prescription Drug Relief Act of 2019 (Cassidy) - Part D smoothing S. 3000, Patient Shared Savings Act (Cassidy) - prescription drug plans S. 3001, Permanent Relief for Seniors and Medicare, Medicaid, Human Services Extension Act of 2019 (Toomey) - extensions S. 3029, Territories Medicare Prescription Drug Assistance Equity Act of 2019 (Menendez) - Territories, low-income Medicare part D beneficiaries S. 3078, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2019 (Grassley) - Medicare appeals process S. 3129, Lower Costs, More Cures Act of 2019 (Crapo) - drug pricing H.R. 19, Lower Costs, More Cures Act of 2019 (Walden) - drug pricing H.R. 259, Medicaid Extenders Act (Pallone) - MFP demonstration, spousal impoverishment protections H.R. 448, Medicare Drug Price Negotiation Act (Cummings) - Part D price negotiations, formulary changes H.R. 789, Improving Transparency and Accuracy in Medicare Part D Spending Act (Welch) - payments on clean claims H.R. 937, Right Rebate Act (Schrader) - Medicaid drug rebate program H.R. 1034, Phair Pricing Act (Collins) - Part D rebates at the point of sale H.R. 1035, Prescription Drug Price Transparency Act (Collins) - Medicare PBM standards H.R. 1046, Medicare Negotiation and Competitive Licensing Act (Doggett) - Part D price negotiation H.R. 1226, ACE Kids Act (Castor) - health homes for children with medically complex conditions H.R. 1277, State Public Option Act (Lujan) - Medicaid buy-in option H.R. 1301, Mental Health Telemedicine Expansion Act (DelBene) - Medicare coverage of mental health telehealth services H.R. 1342, EMPOWER Care Act (Dingell) - MFP demonstration H.R. 1343, Protecting Married Seniors from Impoverishment Act (Dingell) - spousal impoverishment protections H.R. 1346, Medicare Buy-In and Health Care Stabilization Act (Higgins) - Medicare buy-in option H.R. 1375, PAID Act (Kind) - transparency of Medicare secondary payer information H.R. 1394, Medigap Consumer Protection Act (Doggett) - Medicare supplemental consumer protections H.R. 1551, Quality Care for Moms and Babies Act (Engel) - quality measures in Medicaid and CHIP H.R. 1781, Payment Commission Data Act (Carter) - MedPAC and MACPAC access to drug pricing and rebate data in Medicare and Medicaid H.R. 1839, Medicaid Services Investment and Accountability Act (Ruiz) - MFP demonstration, spousal impoverishment protections, ACE Kids Act, Medicaid drug rebate program, health homes for children with medically complex conditions H.R. 2131, Medicare Advantage Quality Payment Relief Act (Kind-Kelly) - MA benchmark cap H.R. 2757, Creating Lower Cost Alternatives for Your Prescription Drugs Act (Cunningham) - eliminate copay for generic drugs in Medicare Part D H.R. 3107, Improving Seniors' Timely Access to Care Act (DelBene) - Medicare Advantage prior authorization H.R. 3253, Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act (Dingell) - MFP demonstration, spousal impoverishment protections, Medicaid drug rebate program H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act (Neal) - funding for quality measurement initiatives, Medicare coverage of mental health telehealth services, real-time benefit tools in Medicare Part D, Medicare eligibility and enrollment notices H.R. 3461, Community-Based Independence for Seniors Act (Sanchez-Kelly) - Community-Based Institutional Special Needs Plan H.R. 3613, State Accountability, Flexibility, and Equity for Hospitals Act of 2019 (Bilirakis) -Medicaid DSH payments H.R. 3631, Territories Health Care Improvement Act (Soto) -Medicaid funding H.R. 3644, Independence at Home Demonstration Act of 2019 (Burgess)-Medicare demonstration program H.R. 3925, Reducing Barriers to Substance Use Treatment Act (Tonko)- Opioids H.R. 3935, Protecting Patients Transportation to Care Act (Carter)-Medicaid coverage for transportation H.R. 4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 (Lowey)-Health extenders H.R. 4453, Protecting Seniors from Health Care Fraud Act of 2019 (Ruiz)-Distributing information to Medicare beneficiaries to prevent fraud H.R. 4527, Expanding Health Care Options for Early Retirees Act (Malinowski)-Option for first responders to buy-in to Medicare H.R. 4529, Promoting Access to Broadband Act of 2019 (Maloney)-Medicaid H.R. 4583, Medicare Extra Rx Higher Eligibility Limits in Part D Act of 2019 (Schneider) - prescription drug affordability H.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019 (Peters) - biosimilars, Part B H.R. 4618, Medicare Hearing Act of 2019 (McBath) - coverage for certain hearing items and services under part B H.R. 4619, Pharmaceutical Rebates for Excessive Pricing Above Inflation Act (Schakowsky) - drug rebates, Part D H.R. 4620, More Help for Seniors Act of 2019 (Rose) - expand eligibility for low-income subsidies under Part D of the Medicare program H.R. 4621, Collecting and Analyzing Resources Integral and Necessary for Guidance for Social Determinants Act of 2019 (Blunt Rochester) - best practices re social determinants of health H.R. 4628, Better Tools to Lower Costs Act of 2019 (Scanlon) - resource requirements H.R. 4629, Star Rating for Biosimilars Act (Tonko) - biosimilars H.R. 4632, Better Transparency in Information for Medicare Beneficiaries Act of 2019 (Kind) - provides consumers information regarding premiums under LIS benchmark plans H.R. 4649, Capping Drug Costs for Seniors Act of 2019 (Horsford) - cap on beneficiary liability under part D of the Medicare program H.R. 4650, Medicare Dental Act of 2019 (Kelly) - Medicare dental coverage H.R. 4655, Enhancing Retirement Security for Medicare Beneficiaries Act of 2019 (Lee) - eligibility of individuals for premium and cost-sharing subsidies under part D H.R. 4661, Advancing Enrollment and Reducing Drug Costs Act of 2019 (Pappas) - Medicaid in territories H.R. 4663, Freedom from Price Gouging Act (Porter) - drug rebates, Part B H.R. 4665, Medicare Vision Act of 2019 (Schrier) - vision items and services under part B H.R. 4666, To amend title XVIII of the Social Security Act to provide certain low-income territorial residents with automatic eligibility for premium and cost-sharing subsidies under the Medicare program, and for other purposes (Shalala) - Medicare in territories H.R. 4669, Maximizing Drug Coverage for Low-Income Seniors Act of 2019 (Stevens) - auto enrollment and intelligent assignment H.R. 4671, Helping Seniors Afford Health Care Act (Kim) - Medicare affordability and low income beneficiaries H.R. 4676, Protecting Medicare Beneficiaries with Pre-Existing Conditions Act (Schneider) - Medigap H.R. 4699, To amend title XIX of the Social Security Act to remove the matching requirement for a territory to use specially allocated Federal funds for Medicare covered part D drugs for low-income individuals (Gonzales-Colon) - Part D, territories H.R. 4769, Medicare Prescription Drug Savings and Choice Act of 2019 (Schakowsky) - lowering prescription drug costs H.R. 4946, Ensuring Seniors Access to Local Pharmacies Act of 2019 (Welch) - equal access of Medicare beneficiaries to community pharmacies in underserved areas H.R. 4996, Helping Medicaid Offer Maternity Services Act of 2019 (Kelly) - State extension of Medicaid H.R. 5006, Expanding Access to Inpatient Mental Health Act (Emmer) - Medicaid coverage for SUD/mental health for institutionalized H.R. 5039, Life Sustaining Prescription Drug Price Relief Act of 2019 (Lipinski) - part D H.R. 5057, Pass- Through Technical Corrections Act (Tonko) - drug pass-through status under Medicare outpatient payment H.R. 5201, Telemental Health Expansion Act of 2019 (Matsui) - Medicare coverage of mental telehealth H.R. 5232, Road to Recovery Act (Fitzpatrick) - Medicaid and CHIP SUD treatment H.R. 5281, Drug Price Transparency in Medicaid Act of 2019 (Carter) - transparency and spread pricing affordability Discussion Draft, Medicare Part D Reform (Neal-Pallone-Brady-Walden) - maximum out-of-pocket limit, federal reinsurance payments Regulatory Issues: Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, network adequacy and provider directories, encounter data and other data-related issues, and risk adjustment data validation (RADV) audit issues including proposed RADV regulation for MA; bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, Part D direct and indirect remuneration (DIR), and audits); calendar year 2021 policy and technical regulation for MA and Part D; MA and Part D proposed rule on drug pricing changes for 2020; Part D reform, out of pocket limits; issues related to Medicare for All, Medicare buy-in and public option; CMSs price transparency proposal for direct-to-consumer advertisements; issues relating to 2021 Rate Notice and Call Letter; issues related to MLTSS; issues related to proposed changes to removal of safe harbor protection for rebates (proposed rule); in-home health risk assessments; Medicare Medical Loss Ratio issues; implementation of sequestration under the Medicare Advantage and Part D programs; implications of the health insurer fee for MA and Part D plans; application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, enrollment rules, requirements for notice and denial forms, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff; measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training; contracting issues for Dual Eligible SNPs; Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, Part D coverage gap discount program, including employer group waiver plan (EGWP) issues, and other operational issues; issues raised by Part D coverage of new specialty drugs, the Part D non-interference policy and related issues (e.g., preferred pharmacy and any willing pharmacy requirements, standards for network pharmacy reimbursement, and policies regarding sponsor negotiation of pharmacy price concessions); issues related to the international price index; issues related to child and maternal health; issues related to Medicaid supplemental and disproportionate share hospital (DSH) funding; issues related to Medicaid funding for territories; issues related to medical management; issues relating to MA supplemental benefits; Medication Therapy Management Program requirements and the Center for Medicare and Medicaid Innovation (CMMI) Demonstration; MA EGWP issues; CMMI's value-based insurance design (VBID) demonstration; Part D requirements for offering basic and enhanced alternative plans; MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; issues relating to MA and Part D Star Rating system including measures, the methodology for calculating ratings, and the role of the ratings for payment purposes; implementation of the Affordable Care Act (ACA) and the Bipartisan Budget Act of 2018 changes to the Part D coverage gap; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education Program; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; new payment system for physicians under MACRA, including implications for MA and Part D plans; Medicare clinical trials; Medicare/Medicaid integration for dual eligibles, including implementation of the Capitated Financial Alignment Demonstration and related issues (e.g., quality ratings); Medicaid managed care regulations and policies, including CMS's substantial revisions to the managed care regulations, mental health parity rules, the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including block grants, the calculation of the federal medical assistance (federal matching) percentage (FMAP), and intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans including issues raised by Medicaid coverage of new specialty drugs; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues and CHIP reauthorization; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including Medicaid managed care organization provider tax issues; standards for electronic prescribing; implementation of Medicaid changes of interest to Medicaid health plans made in the ACA including Medicaid expansion, the managed care organization (MCO) prescription drug rebate provisions, minimum payments to primary care providers (PCPs), interactions between the Medicaid program and health insurance exchanges, and Medicaid and CHIP maintenance of effort (MOE) requirements; implications of the health insurer fee for Medicaid health plans; issues related to Medicaid Managed long-term care including home and community-based waiver services (HCBS); expanding the availability of Medicare Advantage and Medicaid health plan telemedicine programs; implications of the new non-discrimination rules for health plans participating in public programs; issues related to Medigap coverage; issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); cybersecurity; provider directories; value-based insurance design models; issues relating to prescription drug price blueprint; Part D prescriber enrollment requirements; Part D recovery audit contractor programs; issues relating to enrollment of beneficiaries with ESRD into MA plans; issues related to health homes for children with medically complex conditions; socioeconomic status impacts on star ratings related to MA and Part D programs; and other issues relating to health care reform implementation.

S. 433/H.R. 2573, Home Health Payment Innovation Act. S. 296/H.R. 2150, Home Health Care Planning Improvement Act. Oppose home health and hospice payment cuts and co-pays. Recognition and payment for telehealth services under Medicare and Medicaid. Home health rural add-on payment adjustment. Value based purchasing and bundling. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. S. 2080/H.R. 647, Palliative Care and Hospice Education and Training Act. S. 829, Removing Barriers to Person- and Family-Centered Care Act. S. 1190/H.R. 2594, Rural Access to Hospice Act. H.R. 1839, Medicaid Services Investment and Accountability Act. H.R. 3253, Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act. Lifespan Respite Reauthorization Act. Medicare outreach and enrollment efforts to low-income beneficiaries. H.R. 2878, Homecare for Seniors Act. Hospice quality of care and survey reforms. Medicare Time-limited equitable relief. Medicaid payment and eligibility policy. Medicaid Money Follows the Person. Medicaid protections against spousal impoverishments. Increasing the federal budgetary caps as mandated by the Budget Control Act of 2011. Medicare Home Infusion Therapy Benefit. S. 2765, Bipartisan Congressional Budget Reform Act. S. 2741/ H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. S. 2807, Hospice Care Improvement Act of 2019. Extending Medicaid funding in US territories.

Client expense: $150,000 · Firm income: Not reported

H.R. 2740 Labor-HHS Appropriations bill, FY 2020 - lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re Patient Protection and Affordable Care Act. H.R. 2150/S. 296 - Home Health Care Planning Improvement Act. Discussed advancing supportive housing solutions that advance healthy aging in communities. H.R. 3 - Discussed inclusion of dental, hearing, and vision benefit in Medicare. Discussed changes to Medigap policy. S. 1895 - Discussed surprise billing. No bill number - Discussed Medicare late enrollment penalties, eligibility, and financing. S.1999 - Improving Low Income Access to Prescription Drugs Act. No bill number. Discussed Medicaid managed long-term services and supports, including grievances and appeals, with GAO. No bill number. Discussed Medicare and family caregiving. No bill number. Discussed nursing home issue. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act of 2019 and H.R. 1682, the Improving Access to Medicare Coverage Act. No bill number. Discussed Nursing Home Compare. No bill number. Discussed Medicare and respite. No bill number. Discussed hospice issues and legislation. S. 2807, Hospice Care Improvement Act. No bill number. Provided feedback on home and community-based services bill. S. 2574, Promote Responsible Oversight and Targeted Employee Background Check Transparency for Seniors Act. H.R. 5757 -The Fighting Medicare Fraud Act of 2018. H.R. 5326 - The Fairness in Nursing Home Arbitration Act. H.R. 1158, Consolidated Appropriations Act, 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020 - supported permanent extension of Money Follows the Person Rebalancing Demonstration Program and Medicaid home and community-based services spousal impoverishment protections No bill number. Provided feedback on long-term care pharmacy bill. S. 548/H.R. 1342, EMPOWER Care Act, and H.R. 3253, Sustaining Excellence in Medicaid Act - supported longer-term extensions of the Money Follows the Person Rebalancing Demonstration Program and Medicaid home and community-based services spousal impoverishment protections.

Issues concerning access to the Medicare hospice benefit. S. 1190 / H.R. 2594, Rural Access to Hospice Act of 2019 and issues involving access to hospice for Rural Health Clinic (RHC) and Federally Qualified Health Clinic (FQHC) patients. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to advanced care illness management. Issues related to regulatory relief. S. 2807, Hospice Care Improvement Act of 2019 and issues regarding hospice program integrity.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647 / S. 2080); Rural Access to Hospice Act (S. 1190 / H.R. 2594); Patient Choice & Quality Care Act; Provider Training in Palliative Care Act (S. 1921). Hospice program integrity; S. 2807, the Hospice Care Improvement Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for the Medicare hospice benefit; Palliative Care and Hospice Education and Training Act (PCHETA) (H.R. 647 / S. 2080); Rural Access to Hospice Act (S. 1190 / H.R. 2594); Patient Choice & Quality Care Act; Provider Training in Palliative Care Act (S. 1921). Hospice program integrity; S. 2807, the Hospice Care Improvement Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 433/H.R. 2573, Home Health Payment Innovation Act of 2019; Value based purchasing demonstration for home healthcare; S. 2807, Hospice Care Improvement Act of 2019; Hospice issues

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models; hospice program integrity; Hospice Care Improvement Act of 2019 (S.2807); Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); National Hospice and Palliative Care Month Proclamation

Client expense: $193,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Hospice and Medicare Advantage; hospice payment reform; hospice alternative payment models; hospice program integrity; Hospice Care Improvement Act of 2019 (S.2807) Rural Access to Hospice Act (H.R.2594/S.1190); Palliative Care and Hospice Education and Training Act (H.R.647/S.2080); Provider Training in Palliative Care Act (S.1921); National Hospice and Palliative Care Month Proclamation

Client expense: $193,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019; S. 2807 - Hospice Care Improvement Act of 2019.

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE